EcoDrugPlus

Dopamine Receptor D1b

Ensembl ID : ENSOTSG00005035978
Gene Symbol: DRD1B
1 Cross references
192 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSOTSG00005047581
Gene Symbol: DRD1B
1 Cross references
192 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSOTSG00005043432
Gene Symbol: DRD2
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSOTSG00005022314
Gene Symbol: DRD2A
1 Cross references
203 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOTSG00005016174
Gene Symbol: DRD3
1 Cross references
194 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSOTSG00005015283
Gene Symbol: DRD3
1 Cross references
189 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSOTSG00005009324
Gene Symbol: DRD4A
1 Cross references
131 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOTSG00005009451
Gene Symbol: DRD5
1 Cross references
141 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOTSG00005006900
Gene Symbol: DRD5
1 Cross references
140 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSOTSG00005047576
Gene Symbol: DRD5
1 Cross references
140 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2

Ensembl ID : ENSOTSG00005041842
Gene Symbol: LOC112250875
3 Cross references
206 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSOTSG00005025124
Gene Symbol: ENPP2
3 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).